Spherix About Investors Media Center Careers Contact
older and younger smiling couples
Breaking.News
Spherix Reports 1st Quarter Earnings
>more»
 
Spherix Holds Annual Shareholders Meeting
>more»
 
Market Research Shows Spherix’s Naturlose® Readily Accepted by Diabetes Patients Meets MD’s Treatment Need
>more»
 
||View All||
Biospherix
Innovative biotechnology solutions for nutrition and health.

Spherix Health Sciences Consulting
Expert support through the lifecycle of our clients' products.

Annual Report
Product.Spotlight
 

Naturlose
 
Naturlose® (tagatose) is currently undergoing testing in a phase 3 clinical trial as a treatment for Type 2 diabetes.
Innovations for health, Information for Public services, Services for public parks